Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Neuphoria Therapeutics (NEUP) Accumulated Depreciation & Amortization (2021 - 2024)

Neuphoria Therapeutics has reported Accumulated Depreciation & Amortization over the past 2 years, most recently at $45722.0 for Q2 2024.

  • Quarterly Accumulated Depreciation & Amortization changed N/A to $45722.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $45722.0 through Jun 2024, changed N/A year-over-year, with the annual reading at $45722.0 for FY2024, N/A changed from the prior year.
  • Accumulated Depreciation & Amortization was $45722.0 for Q2 2024 at Neuphoria Therapeutics, up from -$75870.5 in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $45722.0 in Q2 2024 and troughed at -$75870.5 in Q2 2021.